InvestorsHub Logo
Followers 826
Posts 119450
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Friday, 09/22/2017 4:17:14 PM

Friday, September 22, 2017 4:17:14 PM

Post# of 866
FDA approves Keytruda in third-line gastric cancer for patients with PD-L1 expression ≥1%:

http://www.mrknewsroom.com/news-release/prescription-medicine-news/fda-approves-mercks-keytruda-pembrolizumab-previously-treate

This is an accelerated approval based on ORR. The PDUFA date was today.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News